OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Erectile dysfunction (ED) is the inability to get or keep an erection firm enough to have sexual intercourse. It is also sometimes also referred to as impotence. Occasional ED is not uncommon. Many men experience it during times of stress. It is sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity.
Symptoms: Trouble getting an erection. Trouble keeping an erection. Reduced sexual desire.
Diagnosis: Some of the tests such as Complete blood count, Liver and kidney function test, Lipid profile, thyroid function test, Urinalysis, Duplex ultrasound, Vasoactive injection, bulbocavernosus reflex. Oral medications are a successful erectile dysfunction treatment for many men. They include: Sildenafil (Viagra) Tadalafil (Cialis) Vardenafil (Levitra, Staxyn) Avanafil (Stendra)
Epidemology: The response included 4489 evaluable replies (56.1%). The response rates in different age groups ranged from 49.2% to 68.4%. Regular sexual activity was reported by 96.0% (youngest age group) to 71.3% (oldest group). There were 31.5%-44% of responders who were dissatisfied with their current sex life. The prevalence of ED was 19.2%, with a steep age-related increase (2.3-53.4%) and a high co-morbidity of ED with hypertension, diabetes, pelvic surgery and 'lower urinary tract symptoms'. When treatment need was defined by co-occurrence of ED and dissatisfaction with sex life, 6.9% men required treatment for ED. Oral treatment of ED was preferred by 73.8% of respondents.